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Abstract. Many neurons in the mollusc Aplysia are 
identifiable and provide a useful model system for 
investigating the cellular mechanisms used by the neu- 
roendocrine system to mediate simple behaviors. In 
this study we determined the subcellular localization 
of eight Aplysia neuropeptides using immunogold la- 
beling techniques, and analyzed the size distribution 
of dense core and granular vesicles in peptidergic neu- 
rons. Recent observations demonstrate that many 
neurons use multiple chemical messengers. Thus, an 
understanding of the functional significance of co- 
transmitters requires an analysis of their relative sub- 
cellular distributions. The peptides are expressed in a 
subset of neurons, or the exocrine atrial gland, and are 
primarily localized to dense core vesicles. Multiple re- 
gions of precursors which are cleaved into several 
components are co-localized. Each neuron has a dis- 
tinct size distribution of peptide-containing dense core 
vesicles ranging in size from 65 to 600 nm. The atrial 
gland contains very large (up to 2 um) peptide-con- 
taining granules. Single neurons have multiple popula- 
tions of granules whose quantal sizes agree with pre- 
dictions based on physical constraints. Some cells con- 
tain very large peptide-containing granules which are 
found in the cell soma and not in processes. Thus, the 
genetic determination of neuronal cell type includes 
not only transmitter choices but also multiple modes 
of packaging the intercellular messengers. 
IOLOGICALLY active peptides  are  frequently used  as 
extracellular chemical messengers in the central nerv- 
ous system (CNS) ~  (19, 25, 29). Neuropeptides have a 
variety of characteristics that distinguish them from the more 
classical  neurotransmitters. For instance, the actions of pep- 
tides are less often constrained to the synapse. In addition, 
peptides are synthesized as parts of larger precursors in the 
cell soma, whereas small molecule transmitters are most often 
synthesized in the nerve terminal (3, 9, 1  l, 28). Single neurons 
have been shown to use more than one chemical messenger, 
often  choosing  a  classical  transmitter  and  one  or  several 
peptides (29). To understand the integrative processes of the 
nervous system, it is necessary to map out both the synaptic 
contacts and the interactions mediated by peptides as well as 
classical transmitters. 
We are particularly interested in the roles of neuropeptides 
in  governing behavioral processes.  The gastropod  mollusc 
Aplysia californica  is a useful model system for these studies 
due to the numerical simplicity and accessibility of the CNS. 
Many neurons are  readily identifiable based on their size, 
color, shape, location, and endogenous electrical activity ( 14, 
19). The roles of a  number of these cells in neural circuits 
that govern simple behaviors have been defined using physi- 
ological techniques (2 l, 22, 46, 55). 
The most widely studied components of the Aplysia CNS 
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are the buccal and abdominal ganglia  (Fig.  1).  The buccal 
ganglion is situated on the buccal musculature and mediates 
a variety of activities associated with feeding (22, 27, 30). The 
abdominal ganglion governs a  number of reflex and fixed 
action patterns including withdrawal of the gill, inking, and 
egg laying (18, 21, 22, 45). 
Many of the identified Aplysia neurons have been shown 
to synthesize large amounts of specific low molecular weight 
proteins which  are thought to be  neuropeptides and  their 
precursors (1, 3, 15, 20, 53, 56). In some cases these peptides 
have been purified, characterized, and shown to have biolog- 
ical activities (2, 25,  39, 40). Our approach has been to use 
the techniques of  recombinant DNA to isolate genes encoding 
these prevalent low molecular weight proteins and to study 
the flow of information from gene expression to the function 
of  the protein product. Using differential screening techniques 
we have isolated the genes encoding the precursors for pep- 
tides expressed in the buccal ganglion cells B1  and B2 (30), 
the bag cells, atrial gland (46), and abdominal ganglion neu- 
rons R3-14 (33), L11 (51), and R2 (44) (Fig.  1). 
We have generated antibodies to component peptides of 
these precursors using either synthetic peptides defined from 
the sequence of  the gene, peptides isolated from Aplysia  tissue, 
or commercially available peptides.  These antibodies were 
used to map the positions of immunoreactive cell bodies and 
processes in  the Aplysia CNS.  Small  networks of neurons 
ranging from as few as 13 to as many as 100 cells react with 
the  various antibodies.  The neurons send  processes to the 
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neuropile, the connective tissue sheath, or specific peripheral 
targets such as the heart or the body wall (24,  27,  31, 32, 44, 
52). 
In this report we present the results of an immunoelectron 
microscopic  study of the subcellular  localization of the pep- 
tides. Determining the subcellular distribution of the peptides 
furthers our understanding  of their biogenesis and suggests 
functional roles. The immunoreactivity is largely localized to 
dense core vesicles (DCVs) and a quantitative analysis of the 
size distribution of the DCVs is presented. Based on size and 
morphology, each cell has a characteristic and complex set of 
granules. 
Materials and Methods 
Tissue 
Ap(vsia californica from 50-500  g were obtained  live either by expedition or 
from Sea Life Supply (Sand City, CA) and maintained  in a seawater tank until 
use. Generally, ganglia and atrial glands were removed from the animals and 
immediately fixed appropriately for analysis. 
Antibodies 
The  preparation  of many of the  antibodies  used  in  this  study  have  been 
previously reported  (24, 27,  44,  52). Antisera  against  PheMetArgPhe-amide 
(FMRFamide) was generously provided by Dr. Eckard Weber (54). All antisera 
used  were generated  in  rabbits  and separated  from the  coagulant  blood  by 
centrifugation. Further purification was not necessary. 
Electron Microscopy 
Neurons used for the vesicle size distribution  analysis were fixed in ganglia for 
4-6 h in 4% glutaraldehyde, 2% paraformaldehyde,  I% acrolein,  1% dimethyl 
sulfoxide. 0.3M  sucrose in  PBS (0.01 M phosphate,  0.15 M NaCI), pH 7.4. 
Figure  1.  Buccal  and abdominal ganglia of Aplysia. 
(A) The caudal  surface of the buccal  ganglia is dia- 
grammed,  showing the  major  nerves and  identified 
cells.  Cells are identified by a  B  followed by an L  or 
R  for left  or  right  hemiganglia and  a  number. The 
shaded  neurons are some of the cells which express 
the gene encoding the small cardioactive  peptides A 
and B.  Neurons B1  and B2  were used in this study. 
(B) The dorsal surface of the abdominal ganglion with 
identified cells indicated by an L  or R  for left or right 
hemiganglia and an identifying number. The bag cells, 
R3-8  and RI4, L11,  and RI5  are among the pepti- 
derglc cells studied in the report. 
After several washes, the neurons of interest were dissected free, and osmicated 
(2% in PBS) for 2 h. Atrial gland tissue was treated in the same fashion. Excess 
osmium was removed  and tissues stained  en bloc with 2%  aqueous  uranyl 
acetate for 2 h, then washed in double-distilled H20, dehydrated stepwise in a 
graded EtOH  series, transferred to propylene oxide, and gradually infiltrated 
and  embedded with Epon-Araldite. Thin (65-70  nm) sections were cut on a 
diamond  knife, mounted on formvar-coated copper grids, and examined and 
photographed on a Philips 410 transmission electron microscope. 
Immunoelectron Microscopy 
Ultrathin Cryosections. Ganglia were fixed in 4% paraformaldehyde, 0.7 M 
sucrose in PBS, pH 7.4, for 4 h, and single neurons were dissected free. These 
were then fixed overnight in the same fixative, and washed several times. The 
neurons were then  infiltrated  with  10%  gelatin,  and  the  gelatin  hardened; 
neurons were then  fixed in 4%  paraformaldehyde/0_7  M sucrose overnight, 
then infiltrated with 2.3 M sucrose. The neurons were mounted on small stubs 
and quickly frozen by plunging into liquid Freon. Uhrathin cryosections were 
cut on glass knives at -110*C  in a Reichert FC4 cryo-unit, collected on drops 
of 2.3 M sucrose, and placed on formvar-coated nickel mesh or slot grids. The 
excess sucrose and fixative was removed by floating for  10  min in  50 mM 
NH4CI in PBS containing  1.5 g glycine/liter. Grids were transferred to drops of 
4% BSA, PBS-glycine for 10 min, to primary antisera diluted  l: 100 for 30-60 
min, washed three  times in PBS-glycine, and transferred to prolein A-coated 
gotd colloid of  6 or i0 am (PA-Au6 or PA-AuI0, respectively) for 20-40 mir~. 
The PA-Au complexes and gold colloids were prepared  using the method  of 
Slot and Geuze (47); PA was obtained  from Pharmacia  Fine Chemicals (Pis- 
cataway, N  J) or Boehringer Mannheim  Biochemicals (Indianapolis,  IN). The 
grids were washed several times in PBS--glycine, then for 10 min in 1 M NaCI, 
then several times in double-distilled H20 (5, 38). Grids were dried and observed 
on the Philips 410 transmission electron microscope. 
Lowicryl K4M. Ganglia and other tissue of interest including atrial glands 
and components of the Aplysia  cardiovascular system were fixed in 4% para- 
formaldehyde, 0.1% giutaraldehyde, 0.1% acrolein,  1% dimethyl sulfoxide, 0.3 
M sucrose in PBS, pH 7.4, 4 h-overnight.  Excess fixative was cleared for 2 h 
in 50 raM NH4CI-PBS, tissues stained en bloc for 2 h with 2% aqueous uranyl 
acetate,  and  dehydrated  in  a  graded  ethanol  series at  20°C to  100%, then 
gradually  infiltrated  with  Lowicryl K4M  resin  (Pelco) and  polymerized  at 
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nickel grids, which were allowed to dry at least 1 h. These were floated on drops 
of 50 mM NH4CI for  10 rain, transferred to 4% BSA for 10 min, and reacted 
with the  antisera at  I:100 dilution for 40  rain at room  temperature.  After 
washing with PBS three times, the grids were transferred to PA-Au as above 
for 20-30 rain, washed in PBS three times, and then H20 three times, dried 30 
rain, and stained 10 rain with 2% aqueous uranyl acetate. For double-labeling 
experiments, after the first PA-Au complex, the grids were floated on 0.1  mg/ 
ml PA for  10 rain, and then briefly washed; the second antisera and PA-Au 
complex were  reacted  in  the  same  way.  Gold  colloid preparations used  in 
double-labeling experiments were of sufficient homogeneity such that <5% of 
one size particle could be mistaken for the other: ~20% of our preparations 
were adequate for these experiments. (See Fig. 5, D and E, for examples of the 
preparations). The  results of our double-labeling experiments cannot be ex- 
plained  by  inhomogeneity  of  the  PA-Au  complexes.  Appropriate  control 
experiments were performed  for  both  immunoelectron labeling techniques, 
including: incubation of tissue directly with PA-Au  to  identify nonspecific 
absorption;  incubation  of sections using antisera blocked with  its antigen; 
incubation with antisera followed by unlabeled PA before the PA-Au; incuba- 
tion with antisera followed by PA-Au preabsorbed with an excess of IgG; and 
incubation with preimmune sera or a serum recognizing peptides localized to 
other neurons in place of the primary antisera (5, 38). 
Im m unofluorescence 
l-~m  Lowicryl sections from  the same blocks used  in the  immunoelectron 
microscopy were dried onto glass slides for  30  min.  Primary antisera in  a 
solution containing 0.4%  saponin,  2%  BSA,  0.1%  normal goat serum  was 
applied for 6  h at 4"C; excess was removed by washing several times in PBS, 
and a  secondary goat anti-rabbit fluorescein isothiocyanate conjugate (Miles 
Laboratories Inc., Elkhart, IN) at a  1:50 dilution in 0.4% saponin, 1% normal 
goat serum, PBS, and reacted for 2 h at room temperature in the dark. Slides 
were  washed and  coverslipped for  examination on  a  Zeiss epifluorescence 
microscope. 
Digitization of Vesicle Sizes 
Electron micrographs were made of random sections of single cells through at 
least three different levels. Using a Bioquant program (R&M Biometrics, Inc., 
Nashville, TN), the diameters of single vesicles were measured on a  Houston 
Instruments digitizing tablet. In some cases the areas and perimeters were also 
measured for the same vesicles. Control for resolution of the digitizing  technique 
was affected by using circles of five sizes covering the range of vesicle sizes 
encountered, and measuring these diameters repeatedly, but not successively. 
To control for the possibility  of differences in individual cells, we measured the 
sphere diameters in three individual RI4 neurons (data not shown). Single cells 
were also analyzed for BI-B2, and LI 1.  In all cases, the overall distributions 
seen in the total histogram were reflected in measurements from  individual 
cells; however, the frequencies at each peak were somewhat variable. Since each 
single cell histogram consists of only -200 DCVs, the sampling error is larger~ 
possibly resulting in variable frequencies. 
Estimation of  Sphere Diameters 
The raw data was grouped into bin sizes of 10 nm. The limit of resolution on 
the  digitizer was 3  rim,  and  therefore  no  additional information would  be 
gained by a smaller bin size. Because of the large span of sizes covered by the 
vesicles in the bag cells and atrial gland, bin sizes of 40 nm (bag cells) and 100 
nm  (atrial  gland)  were  used.  The  method  of Cruz-Orive  (8)  was  used  to 
transform the data from profile diameters to sphere diameters. This method 
gives a  distribution-free estimate of sphere diameters by taking into account 
the minimum size profile observable and the capping angle (8). The minimum 
size cut used was 30 nm to avoid confusing DCVs with other cellular compart- 
ments. The capping angle was determined to be 35* using the method suggested 
by Cruz-Orive (8). The algorithm was implemented on an IBM PC. No dramatic 
changes in the shape of the histograms was observed because of the transfor- 
mation, although several of the bin sizes showed significant frequency shifts. 
This was usually the case when there was a  large shift upward between bins. 
The shift is heightened in the transformed histogram due to the assumption 
that many of the profile diameters in the smaller bin size were oblique cuts of 
the immediately higher bin size. 
Gaussian Fits to Histograms 
The number of populations in each neuron was estimated from the number of 
peaks in the histograms, and the shape of the Q-Q plot. Adjusted Q-Q plots 
(13) were used to estimate starting points for the calculation. A  least squared 
iterative algorithm (13)  was then  used to  determine the best  fit.  When  the 
number of populations was ambiguous from the histogram and Q-Q plot. then 
a fit to all of the possible numbers of populations was carried out. A fit with 
an extra population was only included if it improved the mean squared error 
by a factor of 2. 
Results 
The Small Cardioactive Peptides A and B (SCPA and 
SCPn) 
SCPA and SCPB are 11- and 9-amino acid-amidated peptides 
which share the carboxy-terminal 7 amino acids. The SCPs 
are found in tandem on a  single  136-amino acid precursor 
just after the signal sequence (Fig. 2A) (30). The peptides are 
expressed throughout  the  CNS;  however,  90%  of the  SCP 
activity originates from neurons in the buccal ganglion, sug- 
gesting that these peptides play a role in feeding behavior (27). 
The subcellular distribution of the SCPs was investigated 
in buccal neurons BI  and B2 (Fig.  2, B-D). These cells are 
easily identifiable on the ventral surface of the ganglion and 
send processes to the  esophagus (Fig.  IA) (21,  22,  27).  A 
section through an osmium-stained B 1 or B2 neuron reveals 
the expected organelles including the nucleus, mitochondria, 
endoplasmic  reticulum,  and  Golgl  region  (Fig.  2B).  The 
characteristic DCVs seen in all of the peptidergic neurons are 
quite apparent. A histogram of DCV sizes suggests  a  multi- 
modal distribution with two main peaks centered on 73 _+ 15 
and 106 +_ 16 nm. 
Antisera was generated against commercially available syn- 
thetic  SCPB coupled to  BSA  with  carbodiamide  (27).  The 
antisera was reacted with  ultrathin  sections of a  Lowicryl- 
embedded B2 soma, followed by washes and a second incu- 
bation with protein A coupled to 6-nm colloidal gold (PA-6) 
(Fig.  2C).  The  gold  particles  are  observed within  DCVs, 
demonstrating localization of the peptide immunoreactivity 
to these organelles. Few gold particles are seen in the cyto- 
plasm, suggesting that the  antibody may not recognize the 
precursor protein, a common situation with small amidated 
peptides. Most vesicles contain material which reacts with the 
antisera; in contrast, another membrane-enclosed organelle, 
the mitochondrion, displays no label (Fig. 2 C). 
The limit of resolution for the PA-Au technique has been 
estimated at 16 nm for 3-nm gold particles, based on the size 
of the  PA-Au-IgG complex (38);  therefore,  gold  particles 
within this distance (or correspondingly greater for larger gold 
particles) of DCVs probably represent intravesicular antigen 
recognition. It is likely that for antigen recognition to occur, 
a  vesicle must be cut in  such a  way that the  contents are 
exposed to the surface which comes into contact with anti- 
body.  Therefore,  vesicles  below  the  upper  surface  of the 
section may appear not to contain peptide (5, 38). 
SCPB immunoreactive DCVs of the same size present in 
B2 soma are found in processes and terminals innervating the 
esophagus, salivary gland, and accessory radula closer muscle. 
A section of Lowicryl-embedded esophagus reacted with anti- 
SCPB antisera followed by PA-15 is shown in Fig.  2D. The 
concentration  of label is significantly above background in 
the process displayed. 
FMRFamide 
Antisera against the tetrapeptide FMRFamide  react specifi- 
cally with ~ 100 neurons in the Aplysia CNS. These neurons 
771  Kreiner el al. Aplysia Neurosecretory  Peptides Figure 2. Distribution of the small cardioactive peptide B in B 1 and B2. (A) Schematic representation of the precursor encoding the SCPs. The 
signal sequence is indicated by the black box and approximate position of signal sequence cleavage by the arrow. The positions of proteolytic 
cleavage are indicated by the lines; an NH2 above the line indicates carboxy-terminal amidation of the peptide. The homologous regions of 
SCPA and SCPB are indicated by the stippled region. An S below the precursor indicates the position of a cysteine.  The bracket above the 
precursor schematic indicates the region used to raise antibodies, in this case SCPB. The dashed bracket indicates a homologous region, SCPA, 
which is likely  to cross-react with the antibody. Bar, 20 amino acids. (B) Section of an osmicated B 1 or B2 neuron. N, nucleus; M, mitochondria; 
ER, endoplasmic reticulum; and G, Golgi region. DCVs are present in two size classes (see Table I). Bar, 300 nm. (C) Lowicryl-embedded  B2 
neuron section reacted with anti-SCPB antibody followed by 6-nm colloidal gold coated with protein A. Most of the gold particles are over 
dense core granules. N, nucleus; M, mitochondria. Bar, 200 nm. (D) Process in Lowicryl-embedded  esophagus section, reacted with anti-SCPB 
antisera, followed by PA-15. Bar, 400 rim. 
include the identified cells R2,  LP1,  L12,  and L13  (44).  R2 
synthesizes acetylcholine as well as FMRFamide, and sends 
processes to the body wall where they terminate on mucus- 
secreting  cells  (37)  (Fig.  1B).  The  precursor  encoding 
FMRFamide gives rise to as many as  19 copies of the tetra- 
peptide (Fig. 3A). The spacer region between the peptides is 
usually 8  amino  acids and quite acidic, resulting in  an  ap- 
proximately neutral precursor. Further studies of this unusual 
precursor are in progress. 
Unlike  the  other  neurons  investigated in  this  study,  R2 
does not contain a  large number of dense core granules. The 
size  distribution  of vesicle  profiles  is  fit  well  by  a  single 
gaussian curve having a mean diameter of 65 nm (see Fig. 3B 
and Fig. 8, A and B). Another very rare class of large granules 
are found to have a mean diameter of 300 nm. Antisera raised 
against  synthetic  FMRFamide  was  reacted  with  Lowicryl 
sections of neuron  R2.  Control  experiments to  insure  the 
specificity of the reaction included reaction of the antibody 
with synthetic peptide prior to staining tissue sections or using 
preimmune sera as the primary antibody (5,  38) (Fig. 3 C). 
Fig. 3D shows staining of an  R2 cell soma. The staining is 
specific and a large fraction of the particles are over recogniz- 
able DCVs as indicated by the arrows. Some particles which 
appear to  be  staining above background do  not  appear in 
DCVs.  There  are  several  possible  explanations:  some 
FMRFamide may indeed be free in the cytoplasm; the non- 
DCV  FMRFamide may be a  tissue-processing artifact (that 
is, the peptide may not be adequately fixed in situ); the peptide 
The Journal of Cell Biology, Volume  102,  1986  772 Figure 3. Distribution of FMRFamide immunoreactivity in R2 . (A) Schematic of an FMRFamide precursor . The arrows and lines indicate
positions ofpotential proteolytic cleavages at dibasic or single basic residues respectively ; anNH2 indicates amidation . The FMRFamide regions
are indicated by the horizontal lines . The brackets above are regions that will react with the antibody used in this study ; in this case all of the
units are FMRFamide . Bar, 20 amino acids. (B) Section ofan osmicatedR2 soma . M, mitochondria; G, Golgi region . The arrowheads point
to dense core granules . Bar, 300 nm. (C) Immunoelectron microscopic staining of the R2 soma reacted with anti-FMRFamide which had first
been blocked by incubation with 10 ng/A1 of the peptide. The arrowheads indicate DCVs ; very few gold particles are seen in the section . Bar,
200 nm . (D) Anti-FMRFamide immunoelectron microscopic staining of the R2 soma. PA-6 was used to visualize the antibody . N, nucleus .
Arrowheads point to dense core granules . Bar, 200 nm .
Figure 4 . Localization oftheLl I pep-
tide . (A) The LI I peptide precursor.
Large and small arrows indicate posi-
tions ofpotential cleavage ofthe signal
sequence and internal proteolytic
cleavages, respectively . S represents
cysteine residues and Prepresents the
positions of 13 proline residues.
Brackets indicate two regions of the
precursor where peptides were synthe-
sizedandused to raise antibodies.An-
tipeptide I was used in this study . Bar,
20 amino acids. (B) Section of an
osmicated Lll soma. N nucleus ; G
Golgi region ; M, mitochondria. The
arrowheads indicate large and small
dense core granules. Bar, 300 nm . (C)
Cryoultramicrotome section of an
L11 cell body reacted with anti-pep-
tide I followed by PA-6 . The arrow-
heads indicate large and small DCV
as inB. Bar, 200 nm .
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in these micrographs. 
The Lll  Peptide 
L I 1  is a  cholinergic  neuron  located  on  the  left side  of the 
dorsal  surface of the abdominal  ganglion which sends proc- 
esses to the body wall below the mantle shelf (Fig.  1 B) (21, 
22).  While  no  biologically  active  peptides  have  yet  been 
identified,  a  precursor protein  specifically expressed  in  L11 
has been characterized (51).  A  schematic of this proline-rich 
Figure 5. Localization of the RI4 
peptide. (A) Schematic diagram of 
the R I4 peptide precursor.  Large 
and  small  arrows  indicate  signal 
sequence and internal  proteolytic 
cleavage sites,  respectively. S  rep- 
resents  a  cysteine residue.  The  + 
and -  symbols denote acidic and 
basic  portions  of  the  precursor. 
Three peptides, denoted 1, II, and 
III, were synthesized and used to 
raise  antibodies  as shown  by  the 
brackets above the precursor. Bar, 
20 amino acids. (B) Section of an 
osmicated R14 soma. N, nucleus; 
M,  mitochondria;  ER,  endo- 
plasmic  reticulum.  The  filled  in 
arrowheads indicate DCVs and the 
open arrowheads indicate granular 
vesicles. Bar, 300 nm. (C) Double- 
labeling of R 14 DCVs. A Lowicryl 
section of the Rl4  cell body was 
reacted  with  anti-peptide  II  fol- 
lowed  by  PA-10.  Any  unreacted 
antibody was then blocked with an 
excess  of cold  PA  and  a  second 
antisera,  against  peptide  llI,  was 
incubated  with  the  section  fol- 
lowed by PA-6.  The  large  arrow- 
heads point to PA- 10 and the small 
arrowheads to PA-6, Bar, 200 nm. 
(D) Lowicryl section of  an R 14 cell 
body showing dense (black arrow- 
head) and granular (white arrow- 
head)  vesicles stained  with  anti- 
peptide [II followed by PA-10. Bar, 
200 nm. (E) Cryoultramicrotome 
section of a right upper quadrant 
neuron,  R3-8,  reacted  with anti- 
peptide I followed by PA-6. Arrow- 
heads  indicate  DCVs.  Bar,  200 
nm.  (F)  A  LowicD'l section  of a 
terminal in the muscle of the an- 
terior  aorta.  The  section  was  re- 
acted with anti-peptide 11 followed 
by PA-6. The arrowheads point to 
examples  of  immunoreactive 
DCVs.  M,  mitochondrion.  Bar, 
200 nm. (G) A Lowicryl section of 
the branchial nerve reveals a cross 
section  through  an  R3-14  axon. 
This section was reacted with anti- 
peptide II and  PA-6.  Arrowheads 
indicate DCVs. Bar, 200 rim. 
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hydrophobic leader peptide and two pairs of dibasic residues 
flanking a pair of cysteines. 
Sections of an osmicated L11  soma reveal an architecture 
common to  peptidergic neurons:  extensive Golgi complex 
and DCVs.  The DCV size distribution is quite complex in 
that it cannot be fit well  by a  single  gaussian  distribution 
(Table I). This distribution suggests the presence of multiple 
vesicle size classes as will be discussed later. The large number 
of clear vesicles observed may reflect the cholinergic nature 
of this neuron (16,  17). Two peptides have been synthesized 
and used to raise antibodies (52) (Fig. 4A). Electron micro- 
scopic labeling studies localize the peptide immunoreactivity 
to the multiple size classes of DCVs (Fig. 4 C). 
The R14 Peptide 
The abdominal ganglion neurons R3-14 are thought to be 
both glycinergic and peptidergic (35,  41-43). Our light level 
immunohistochemical studies demonstrated that these cells 
send processes into the vascularized connective tissue sheath 
surrounding the ganglion and connectives, and to the efferent 
vein of the gill at the base of the heart. RI4 is anatomically 
distinct in that it sends immunoreactive processes to other 
regions of  the vasculature including the anterior aorta and the 
abdominal ganglion artery (24, 34, 36). The peptide precursor 
is  108 amino acids and is proteolytically processed at three 
sites including removal of  the signal sequence and cleavage of 
two internal dibasic residues (33) (Fig. 5A). 
R I4 is a large white neuron which is easily identified in the 
right lower quadrant on the dorsal  surface of the ganglion 
(Fig.  1B). The somata contains extensive endoplasmic retic- 
ulum, characteristic of a large amount of secretory product 
biosynthetic activity (Fig. 5 B). In addition, two morphologi- 
cally distinct vesicle types, one containing dense and the other 
granular cores, are seen. Both vesicle types show multimodal 
size distributions; however, the granular vesicles are somewhat 
larger than the DCVs.  The RUQ neurons (R3-13) are the 
only other ceils in Aplysia that express this peptide-encoding 
gene (33); the distribution of  dense core and granular vesicles 
in  these neurons differs from that in  RI4,  having a  wider 
distribution of classes (Table I). 
Three peptides have been synthesized, coupled to protein 
carriers, and used to raise antibodies (24) (Fig. 5A). Immu- 
noelectron microscopic studies demonstrate that each of the 
antibodies recognize antigen in the dense core and granular 
vesicles of  both R 14 and the RUQ (R3-13) neurons, as shown 
in  Fig.  5,  D  and E.  The use of Lowicryl-embedded tissue 
greatly improves the  morphology of the tissue,  allowing a 
clear visualization of the granular vesicles (Fig. 5 D). A num- 
ber of gold particles are seen in the cytoplasm outside the 
granules.  This  staining  is  above  background  and  may be 
attributed to precursor in  the secretory pathway; however, 
Lowicryl sections with  well-preserved membranes  suggests 
that some of the immunorcactivity may be outside the endo- 
plasmic reticulum, Golgi region, or granules. 
To conclusively demonstrate the co-localization of  all three 
regions of the R14 precursor, a series of double-label experi- 
ments were conducted. An example is shown in Fig. 5 C; in 
this case, a Lowicryl section of neuron R 14 was reacted with 
antisera against peptide II followed by PA-Au6, blocked with 
excess PA, reacted with antisera against peptide III followed 
by PA-Aul0, and examined. Both small and large gold par- 
ticles are visible in the majority of DCVs.  Different combi- 
nations of primary antisera demonstrate co-localization of all 
regions of  the precursor. All possible permutations of  antisera, 
PA-Au, and sequence of reaction were examined, and each 
demonstrated the same result. Further control experiments 
included blocking one or both antisera with peptide or using 
normal  rabbit  sera  as  the  primary antibody to  determine 
background (5, 38). 
We have examined the distribution of R 14 peptide immu- 
noreactive DCVs in the nerves exiting the abdominal ganglion 
as well as peripheral targets.  In Fig.  5F,  a  terminal in the 
muscle of the anterior aorta is seen to contain immunoreac- 
tive DCVs. Fig. 5 G shows a cross section through a large axon 
in the branchial nerve which also contains immunoreactive 
DCVs. 
The Egg Laying Hormone (ELH) Gene Family 
Oviposition and  the  associated  behavior is  governed by a 
family of five neuropeptide genes expressed in an exocrine 
gland and the CNS (18,  26,  31,  39, 46,  49).  The genes are 
Table 1. Calculated Frequencies and Sizes for Vesicle Populations in Aplysia Neurons Compared to Predicted Quantal Vesicle 
Sizes 
Mean squared  Quantal vesicle size 
Source  N  error 
Predicted  (6)  69  95  120  172  + 
Predicted  (12)  70  95  120  145  170  195  220  + 
Atrial gland  374  6.7  100% 300-2500 
BI-B2  1222  5.9  26% 73 ±  15  15% 87 _+ 15  48%  106 +  16  11% 148 ±  16 
Bag cells  840  4. I  44%  114 ±  16  46% 159 ± 20  10% 240-600 
L5  420  3.2  55% 81 ±  16  42%  105 ±  18  3%  155 ± 6 
L6  633  2.6  85% 75 ±  16  10%  115 ±  18  5%  136 ±  18 
LI0  594  2.7  38% 75 ±  14  55% 111 ±  17  7%  158± 16 
LII  1140  2.8  72%77-+19  22%110±15  6%153±15 
LI2  493  6.4  48% 88± 13  40%  119-+ 17  12% 152±25 
L13  555  2.2  23%68±22  40%86±10  26%  114±9  6%  138±4  5% 158± 16 
R2  570  5.9  95% 65 ± 21  5% 240--400 
RI4 D('V  604  6.7  37%  126± 15  49%  163± 15  14%208±20 
RI4GR  530  5.3  40%  144± 16  32% 174± 12  14%200±4  14%231  ±  12 
RI5 DCV  720  2.8  11% 64± 8  48%  100± 14  34% 132_+ 16  7%  169±7 
RI5GR  745  3.2  19%79±10  43%110±13  22%147±13  13%176±17  7%225±35 
RUQ I)CV  470  5.1  13%73±  16  23%  119± 16  19% 138±25  20% 163--. 18  25%  199±20 
RUQGR  300  8.2  24%  153± 1  31%  184±6  9%206±4  21%224± 12  15%278±30 
All sizes are in nanometers: N  is the number of vesicles measured for each cell. 
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77690% homologous, yet due to the location of a few key amino 
acid substitutions, different sets of related peptides are cleaved 
from the precursor proteins (45) (Fig. 6A). 
The Atrial Gland.  The atrial gland is situated at the distal 
end of the hermaphroditic duct at the gonopore. The gland 
releases its contents into the lumen of the duct, defining the 
mode of secretion  as exocrine.  An example  of the  class of 
precursor expressed  in  the  atrial  gland  is  illustrated  in  the 
lower part of Fig. 6A. The precursor gives rise to a 34-amino 
acid hormone, peptide A, and a molecule related to ELH. A 
similar precursor (not shown) gives rise to a hormone called 
peptide  B  which  is  homologous to  peptide  A  at  30  of 34 
positions.  While  the  precise  function  of the  gland  is  not 
known, two hypotheses for the function of the peptides have 
been put forth. First, Strumwasser and his colleagues (48) has 
suggested that peptides A  and/or B released from the gland 
initiate  a  bag cell discharge eventually resulting  in  an  egg- 
laying episode.  Alternatively,  behavioral studies  suggest the 
frequency of mating is increased by atrial gland extracts and 
therefore the peptides  may act as pheromones coordinating 
the actions of individuals within the species (50). 
The gland consists of large secretory cells surrounded by 
ciliated  capping cells.  The secretory cells contain very large 
DCVs which are up to 2 #m in diameter (2) (Fig. 6 B). These 
granules are  visible in  the light  microscope when  Lowicryl 
tissue sections are stained with antisera against peptide A or 
peptide B and a fluorescent secondary antibody. Immunogold 
labeling using antisera directed against peptide A  also dem- 
onstrates the presence of the peptide in the vesicles (Fig. 6, D 
and  E).  Antibodies  against  ELH  also  stain  the  granules; 
however, the reaction is weaker than when antisera against 
peptide A is used. 
The Bag Cells.  The major site of ELH gene expression in 
the  CNS  is  the  bag  cells,  although  there  are  many  other 
immunoreactive neurons (32). There are ~800 bag cell neu- 
rons  in  two  clusters  on  the  rostral  side  of the  abdominal 
ganglion. The cells are electrically coupled and fire a  20-30- 
rain train of action potentials called the afterdischarge during 
each egg-laying event (18). The precursor expressed in the bag 
cells encodes a  number of potential  peptide  hormones and 
transmitters. ELH has been shown to have a host of activities 
on central neurons and peripheral tissues (26, 39, 40). Another 
set of candidate peptides,  a-,/3-,  3'-, and d-bag cell peptides 
(BCPs) are contained in the same precursor. The a-BCP has 
actions on abdominal  ganglion  neurons,  largely as a  short 
duration inhibitory transmitter (39). 
The bag cells have a complex distribution of DCVs which 
falls into three discrete size classes (Fig. 7 B, Fig. 8, E  and F, 
and Table I). Two biologically active peptides from the ELH 
precursor have been used to raise rabbit antibodies, the 36- 
amino  acid  ELH and  the  9-amino  acid  a-BCP (Fig.  7A). 
Micrographs of two Lowicryl sections reacted with anti-ELH 
and anti-a-BCP antisera followed by PA-Au6 are shown in 
Fig. 7, C and D. Almost all of the gold particles are associated 
with  DCVs in both cases.  Double-label experiments  as de- 
scribed  for R I4 were performed  on bag cell sections using 
anti-ELH and anti-a-BCP antisera (Fig. 7 E). The experiments 
demonstrate  that  many vesicles contain  both  ELH and  a- 
BCP immunoreactivity. 
Bag cell processes extend rostrally along the pleural abdom- 
inal connective to the head and caudally into the connective 
tissue sheath which surrounds the ganglion (14).  Release of 
bag cell products into the sheath delivers the peptides both to 
central neurons and the circulation for distribution to distant 
targets. Rostral and caudal sheath were processed in Lowicryl 
and examined for immunoreactivity. In Fig. 7 F, a portion of 
the rostral sheath is shown to contain a large number of anti- 
ELH immunoreactive DCVs. The largest size DCVs are not 
seen in the processes suggesting that these peptide-containing 
organelles are soma specific. 
DCV Size Distribution 
Sections of osmicated neuronal cell bodies were photographed 
at three different levels,  often through multiple cells,  and the 
diameter  of the  DCVs  were  measured.  The  raw  data  was 
grouped into either 10-nm or 40-nm bin sizes and the method 
of Cruz-Orive (8) was used to transform the measured profile 
diameters into sphere diameters. 
The histograms generated for the sphere diameters tended 
to be complex, suggesting the existence of multiple size classes 
of vesicles in some of the neurons.  To further examine this 
issue Q-Q plots (13) were constructed from the histogram in 
order to separate possible mixtures of normal distributions. 
Using a least squared iterative algorithm with starting values 
generated  from  adjusted  Q-Q  plots  (13),  a  best  fit  to  the 
histograms for each neuron was calculated (Table I). 
The  R2  DCV sphere  diameter  histogram  (excluding the 
rare very large DCVs) reflects a single component, normally 
distributed,  with a  mean of 65  __. 21  nm (Fig.  8, A  and B). 
None of the other sphere diameter histograms could be fit by 
a  single  normal  distribution.  An  example  of one  of these 
complex distributions is seen in the histogram of R14 DCV 
sphere diameters (Fig. 8 C). The histogram displays a marked 
multimodality.  The lines in the Q-Q plot corresponding to 
Figure 6. lmmunoelectron microscopic localization of peptides in the atrial gland. (A) The ELH and peptide A precursors. The sequences are 
90% homologous and the dashed lines between the precursors indicate the positions of insertions or deletions. The large arrows, small arrows 
and lines indicate positions of signal sequence cleavage and proteolytic processing sites at dibasic or single basic residues, respectively, Some of 
the known peptides are labeled including ELH, peptide A, the acidic peptide, and the a-, B-, 3,-, and ~-BCPs. The peptide B precursor is similar 
to the peptide  A precursor.  In this series of experiments  anti-peptide  A, B and ELH antibodies  were used. Anti-ELH cross-reacts with the 
homologous region in the peptide A and B precursors. Anti-peptide A or B cross-reacts with the homologous region in the ELH precursor 
(asterisks) as denoted by the dashed brackets above the schematic. Bar, 20 amino acids. (B) Section through an osmicated atrial gland showing 
the secretory cells which contain large DCVs. C denotes the cilia of the capping cells which border the exocrine cells. Arrow indicates dense 
material in lumen, probably representing a large secreted DCV. Bar, 1 urn. (C) Light micrograph ofa Lowicryl-fixed section of  the atrial gland 
stained with anti-peptide A followed by goat anti-rabbit coupled to fluorescein isothiocyanate. The arrows point to regions of immunoreactive 
granules. Bar, 5 t~m. (D) Lowicryl section of the atrial gland reacted with anti-peptide A followed by PA-6. The arrow indicates a section of a 
granule which may be in the process of secretion. Bar, 200 nm. (E) Same as D, with PA-15. Bar, 300 nm. 
777  Kreiner et al. Aplysia Neurosecretory  Peptides Figure 7. EM immunohistochemistry ofthe bag cells . (A) Same as in Fig. 6A . In this study, antibodies directed against ELH, region 1, and a-
BCP, region 11 were used . a-BCPhomologous regions are indicated by the stippled regions in theELH and peptideAprecursors . (B)Micrograph
of an osmicated bag cell body . N, nucleus; M, mitochondria;ER, endoplasmic reticulum; G, Golgi region . The three arrows indicate examples
of vesicles belonging to the three different size classes . Bar, 300 nm . (C) Section of a bag cell soma reacted with anti-ELH followed by PA-6 .
Bar, 200 nm . (D) Section of abag cell soma reacted with anti-a-BCP followed by PA-6 . Bar, 200 nm . (E) Double label of bag cell DCVs. The
experiment was done essentially as described for R14 . The PA-6 (small arrowheads) represents ELH immunoreactivity and the PA-10 (large
arrowheads) represents a-BCP reactivity . Bar, 200 nm . (F) Lowicryl section through the pleural abdominal connective sheath revealsabag cell
process containing ELH immunoreactive DCVs. Bar, 200nm .
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Figure 8. DCV size distributions for R2, RI4, and the bag cells. (A) Estimated sphere diameters for R2 DCVs in the range of 30 to  130 nm. 
Larger DCVs were measured, but are not shown on this graph. The fitted gaussian has a mean of 65 ___ 21 nm. (B) Q-Q plot for A adjusted to 
include the range of 30 to  100 nm.  The line is a least squares fit to the points shown (r -- 0.9998).  (C) Estimated sphere diameters for RI4 
DCVs. The fitted gaussians described in Table I for the RI4 DCVs have means of 126 __+_ 15,  163 _+  15, and 208 _+ 20 nm. (D) Q-Q plot for 
the data in C. The lines are least squared fits for the points they cover. These are the regions corresponding to the unmixed portions of the 
histogram in C. (E) Bag cell DCVs sphere diameters with a bin size of 40 rim; inset is a histogram of the smaller DCVs with a bin size of 10 
nm. In the 40-nm bin size histogram, the large DCVs are overrepresented so that their population distribution could be seen. On micrographs 
where both vesicle types were counted, large DCVs (>240 nm) represented 5-10%  of the vesicles seen. The two gaussians fit to the inset are 
the best fit from Table I, having means of 114 +  16 and  159 +  20 nm. (F) Q-Q plot of the data in the inset of E. Again, the straight lines 
represent the unmixed populations separated by a region where the populations are mixed. 
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A third example is seen in Fig. 8 E where the bag cell DCVs 
are  analyzed.  In  the  histogram,  the  profiles  are  initially 
grouped into 40-nm bin sizes to reveal the larger population 
of vesicles between 250 and 600 nm. These large profiles are 
only 5-10% of the number of vesicles;  however, because of 
their large size account for up to 50% of the DCV volume in 
the soma. If one looks more closely at the smaller vesicles by 
grouping them into  10-nm bin sizes,  a clear bimodal distri- 
bution is seen (inset, Fig.  8 E). The Q-Q plot has two lines 
corresponding to each of the populations with a mixing region 
in between the two lines. The region of  the Q-Q plot preceding 
the line is made up of very few vesicles, and this may explain 
its irregularity. Alternatively, there may be a very small pop- 
ulation of small vesicles in the bag cells; the end of the line 
deviates because of the emerging presence of the very large 
DCVs. The estimated vesicle diameter was fit to two gaussians 
using the least squared iterative algorithm with starting esti- 
mates from the  adjusted  Q-Q plot.  The  fit is a  good  one 
(mean squared error =  4.5) and reveals two populations of 
roughly equal representation:  l l4  _+  16  nm  and  159  +  18 
rim, 
There have been reports that the formation of vesicles is 
physically constrained to certain sizes (6, 7). In these studies, 
Bont and co-workers showed that vesicles formed by ultra- 
sonic disruption of membranes were formed in quantal sizes. 
In Table I we have compared the predicted quantal sizes to 
those determined from the measurements in this study, and 
to a theoretical model of vesicle sizes (12).  The data fit the 
model rather well, suggesting vesicle formation in vivo may 
also be subject to physical constraints. 
L5, L6, Ll0, Ll l, and L12 all have a very similar pattern 
of vesicle sizes (Table I). The major difference between these 
neurons is the frequency of the major populations. For in- 
stance, the smaller population makes up 85%  of L6 DCVs 
but only 38%  of the DCVs in Ll0. Bl-B2 and L13 show a 
more complex pattern which could not be fit well until a fit 
of 4  gaussians was attempted. The theory of Bont predicts 
four vesicle size classes in the range covered by these neurons 
(see Table I). Bag cells, R 14, R 15, and RUQ all contain larger 
vesicles than the other neurons. 
Discussion 
Gene products expressed in subsets of reproducibly identifia- 
ble Aplysia neurons are localized in specific classes of DCVs 
in the soma, processes, and terminals. Aplysia is an excellent 
model system for an integrative approach that allows us to 
determine the function of neuroactive peptides and to relate 
the actions of identified  cells to simple behaviors.  We are 
beginning to understand how complex neuronal systems func- 
tion. Additionally, these neurons offer an opportunity to study 
regulated protein secretion (23) and the significance of mul- 
tiple transmitter and vesicle types in Aplysia neurons. 
We have shown that a  number of candidate  neurotrans- 
mitters are contained in DCVs of  Aplysia neuronal cell bodies 
and processes as well as in the exocrine atrial gland. Vesicular 
localization of the peptide products is consistent with their 
functioning as extracellular messengers. The vesicles provide 
a  mechanism whereby molecules are packaged into discrete 
quanta, transported to appropriate terminals, and stored until 
they are required for signaling. Fusion of  vesicular membranes 
with presynaptic terminals allows release of  chemical messen- 
gers that range from small molecules such as acetylcholine to 
larger peptides. 
Previous studies have implicated acetylcholine as a trans- 
mitter in R2, B2, and L11 (16,  17). Acetylcholine is generally 
stored in small (~40-80  nm) clear vesicles;  consistent with 
this hypothesis, neurons B2, R2, and LI 1 have a large number 
of these  vesicles.  It is not  known  whether acetylcholine is 
packaged into DCVs in these cells. Our data suggest that the 
peptides are not found in clear vesicles; it thus appears likely 
that these neurons use two different transmitters which are 
packaged  into  separate  vesicle populations.  This  situation 
would potentially allow differential transport and/or release 
of the different vesicle populations, each containing a unique 
transmitter. Evidence for differentially regulated vesicle pop- 
ulations has been suggested in other cell types (23); sorting is 
likely to  be dependent  on  differences in  vesicle-associated 
antigens. 
Neurons  R3-14  are thought to be glycinergic as well as 
peptidergic; free glycine has been shown to be packaged in 
DCVs and transported to terminals (35,  41,  42,  43).  While 
further co-localization studies are necessary before any firm 
conclusions can be made, the best interpretation of  the current 
data is that glycine and the peptides are packaged in the same 
granules.  This  organization  does  not  have  the  degrees  of 
freedom found in  the  cholinergic systems and  suggests  co- 
release under all circumstances. 
Peptides A and B as well as ELH immunoreactive material 
is localized in the large dense core granules of the atrial gland. 
The function of these granules is not entirely clear; however, 
the exocrine mode of secretion suggests a role as pheromones 
mediating mating activities between individuals (50). The bag 
cell  granules  contain  immunoreactivity to  more  than  one 
biologically active peptide, ELH and the a-BCP. These mol- 
ecules are therefore probably released and may act as a peptide 
co-transmitter system during egg laying in Aplysia. 
The data support the hypothesis that DCVs are synthesized 
in quantal sizes. The sizes and the ratio of the different size 
classes varies from cell to cell and the mechanisms controlling 
this process are not understood. It is curious that R2, which 
expresses the gene with the highest molar ratio of peptide to 
precursor, the FMRFamide precursor, contains the smallest 
DCVs.  The bag cells,  which  express the  most complicated 
precursor, have a  set of very large granules which we have 
shown are immunoreactive with antisera against two peptides 
derived  from  the  precursor.  These  observations  suggest  a 
coupling  of the  DCV  contents,  function,  and  size  of the 
granule. The regulation of the amount of transmitter released 
may  in  part  be  controlled  by  vesicle  size  which  in  turn 
determines the number of molecules per quanta. It is possible 
that the peptide precursor itself determines vesicle and thus 
quantal size. Alternatively, each cell may control vesicle size 
independently of the peptide precursor synthesized. 
We have shown that several neuropeptides are transported 
in DCVs away from cell soma. SCPB is present in processes 
and terminals in components of the feeding system including 
the  esophagus, salivary glands,  and accessory radula  closer 
muscle, where  it is associated specifically with  DCVs.  The 
R14  peptide is contained in DCVs in processes innervating 
the cardiovascular system; it may directly affect these tissues, 
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act as a circulating hormone. Furthermore, we have observed 
ELH immunoreactive DCVs in bag cell processes that extend 
rostrally along the pleural abdominal connective. Only the 
smaller DCVs are observed in these processes, suggesting the 
large DCV class serves a  soma-specific function as sites of 
storage, processing, or turnover. 
Molecular genetic, biochemical, and physiological studies 
in  conjunction with the cellular studies  described  here are 
generating  an  understanding  of the  biogenesis  of peptide 
messengers in the Aplysia nervous system. Because neurons 
must carefully regulate when and where they secrete specific 
substances, further studies of these cells will provide insight 
into mechanisms of transport, sorting, and differential exo- 
cytosis. 
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